Misconceptions and Facts About Hypertrophic Cardiomyopathy - 15/01/16
, Mark V. Sherrid, MD b, Franz H. Messerli, MD aAbstract |
Hypertrophic cardiomyopathy is the most common genetic heart disease. Once considered relentless, untreatable, and deadly, it has become a highly treatable disease with contemporary management. Hypertrophic cardiomyopathy is one of cardiology's “great masqueraders.” Mistakes and delays in diagnosis abound. Hypertrophic cardiomyopathy commonly “masquerades” as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with hypertrophic cardiomyopathy can be effectively managed to improve both symptoms and survival. This review highlights some of the misconceptions about hypertrophic cardiomyopathy. Providers at all levels should have awareness of hypertrophic cardiomyopathy to promptly diagnose and properly manage these individuals.
Le texte complet de cet article est disponible en PDF.Keywords : Echocardiography, Hypertrophic cardiomyopathy, Septal reduction therapy
Plan
| Funding: None. |
|
| Conflict of Interest: EA: None; MVS: None; FHM: consultant or advisory relationships with the following companies: Daiichi-Sankyo, Pfizer, Abbott, Servier, Medtronic, WebMD, IPCA, ACC, Menarini, Relypsa. |
|
| Authorship: The work presented here is original and has not been submitted for publication elsewhere. The authors accept responsibility for the scientific content of the manuscript. |
Vol 129 - N° 2
P. 148-152 - février 2016 Retour au numéro
Article précédent
- Caring for ‘Very Important Patients’—Ethical Dilemmas and Suggestions for Practical Management
- David Alfandre, Sarah Clever, Neil J. Farber, Mark T. Hughes, Paul Redstone, Lisa Soleymani Lehmann
- Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician
- Joseph A. Vassalotti, Robert Centor, Barbara J. Turner, Raquel C. Greer, Michael Choi, Thomas D. Sequist, National Kidney Foundation Kidney Disease Outcomes Quality Initiative
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?